Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (14)

2023

  1. Análisis coste-utilidad del modelo de unidad de terapia intravítrea (UTI) frente a la administración tradicional de terapia intravítrea

    Archivos de la Sociedad Española de Oftalmologia, Vol. 98, Núm. 11, pp. 619-626

2022

  1. The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world

    Acta ophthalmologica, Vol. 100, Núm. 2, pp. e521-e531

2021

  1. Challenges in diabetic macular edema management: An expert consensus report

    Clinical Ophthalmology, Vol. 15, pp. 3183-3195

  2. Recommendations for ophthalmologic practice during the easing of COVID-19 control measures

    Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e973-e983

2020

  1. A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study

    PharmacoEconomics - Open, Vol. 4, Núm. 4, pp. 615-624

  2. Use of intravitreal dexamethasone implants in the treatment of diabetic macular edema: Expert recommendations using a Delphi approach

    European Journal of Ophthalmology, Vol. 30, Núm. 5, pp. 1042-1052

2019

  1. Cohort profile: Design and methods of the PREDIMED-Plus randomized trial

    International Journal of Epidemiology, Vol. 48, Núm. 2, pp. 387-388o

2018

  1. Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration

    Acta Ophthalmologica, Vol. 96, Núm. 2, pp. e201-e212

  2. Clinical decision-making when treating diabetic macular edema patients with dexamethasone intravitreal implants

    Ophthalmologica, Vol. 240, Núm. 2, pp. 61-72

  3. Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials

    JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677

  4. Erratum to “Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost” (The Ocular Surface (2017) 15(4) (723–729) (S1542012416302695) (10.1016/j.jtos.2017.03.004))

    Ocular Surface

2017

  1. Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost

    Ocular Surface, Vol. 15, Núm. 4, pp. 723-729

2016

  1. Safety and efficacy clinical trials for SYL1001, a novel short interfering RNA for the treatment of dry eye disease

    Investigative Ophthalmology and Visual Science, Vol. 57, Núm. 14, pp. 6447-6454

2015

  1. Clinical Evaluation of the New Rebound Tonometers Icare PRO and Icare ONE Compared with the Goldmann Tonometer

    Journal of Glaucoma, Vol. 24, Núm. 7, pp. 527-532